INT25030

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.25
First Reported 1987
Last Reported 1989
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 0
Pain Relevance 0.79

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (FSHR) plasma membrane (FSHR) signal transducer activity (FSHR)
FSHR (Homo sapiens)
Pain Link Frequency Relevance Heat
narcan 12 99.84 Very High Very High Very High
Endogenous opioid 5 75.00 Quite High
Opioid 1 75.00 Quite High
antagonist 1 64.00 Quite High
opiate 1 63.20 Quite High
Disease Link Frequency Relevance Heat
Reprotox - General 1 1 46.28 Quite Low
Congenital Anomalies 1 45.24 Quite Low
Stress 2 43.84 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Addition of naloxone to CRH (5 women) reversed the LH and FSH inhibition when naloxone was started 1 h after the start of the CRH infusion.
Negative_regulation (reversed) of Negative_regulation (inhibition) of FSH associated with narcan
1) Confidence 0.25 Published 1989 Journal J. Clin. Endocrinol. Metab. Section Abstract Doc Link 2493035 Disease Relevance 0 Pain Relevance 0.42
Addition of naloxone to CRF prevented the CRF-mediated suppression of LH and FSH release.
Negative_regulation (prevented) of Negative_regulation (suppression) of FSH associated with narcan
2) Confidence 0.08 Published 1987 Journal Endocrinology Section Abstract Doc Link 3113919 Disease Relevance 0 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox